ACUTA CAPITAL PARTNERS LLC

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Aadi Bioscience, Inc.
AADI
$4.33M7.531.85M0%+$02.81
Taysha Gene Therapies, Inc.
TSHA
$9.57M1.783.33M-7.13%-$734,720.026.22
Mersana Therapeutics, Inc.
MRSN
$9.7M1.772.16M-8.59%-$911,106.526.3
Ocular Therapeutix, Inc.
OCUL
$23.98M1.72.64M+101.17%+$12.06M15.58
Tourmaline Bio, Inc.
TRML
$5.98M1.02261,108+12.6%+$669,275.383.89
Praxis Precision Medicines, Inc.
PRAX
$9.9M0.95162,302-45.83%-$8.38M6.44
Leap Therapeutics, Inc.
LPTX
$942,082.000.93354,1660%+$00.61
Enliven Therapeutics, Inc.
ELVN
$6.97M0.84396,099+219.75%+$4.79M4.53
Verastem, Inc.
VSTM
$2.44M0.82207,095-10.83%-$296,817.201.59
Terns Pharmaceuticals, Inc.
TERN
$3.05M0.72465,079-16.24%-$591,587.311.98
Applied Therapeutics, Inc.
APLT
$5.39M0.69792,000+50.83%+$1.81M3.5
HilleVax, Inc.
HLVX
$4.17M0.5250,609-22.8%-$1.23M2.71
Cellectar Biosciences, Inc.
CLRB
$571,130.000.4143,500-69.95%-$1.33M0.37
Rocket Pharmaceuticals, Inc.
RCKT
$8.8M0.36326,787-10.72%-$1.06M5.72
Viridian Therapeutics, Inc.
VRDN
$3.49M0.31199,433-29.15%-$1.44M2.27
Disc Medicine, Inc.
IRON
$4.78M0.3176,800-33.51%-$2.41M3.11
Mereo BioPharma Group plc
MREO
$1.31M0.28397,884New+$1.31M0.85
Lyra Therapeutics, Inc.
LYRA
$1.08M0.28173,320New+$1.08M0.7
Dyne Therapeutics, Inc.
DYN
$5.24M0.19184,500+24.8%+$1.04M3.4
Celldex Therapeutics, Inc.
CLDX
$4.57M0.17109,000+57.06%+$1.66M2.97
ORIC Pharmaceuticals, Inc.
ORIC
$1.43M0.15103,992New+$1.43M0.93
Kura Oncology, Inc.
KURA
$1.92M0.1290,000-87.17%-$13.04M1.25
Crinetics Pharmaceuticals, Inc.
CRNX
$3.67M0.178,403-10.4%-$425,830.522.38
Agios Pharmaceuticals, Inc.
AGIO
$1.62M0.155,262New+$1.62M1.05
Vaxcyte, Inc.
PCVX
$7.16M0.1104,830-10.69%-$856,812.294.65
Revolution Medicines, Inc.
RVMD
$4.63M0.09143,777-10.14%-$522,867.323.01
Sarepta Therapeutics, Inc.
SRPT
$8.31M0.0764,162-9.12%-$833,463.535.4
Arcellx, Inc.
ACLX
$2.4M0.0634,500-55.2%-$2.96M1.56
Immunovant, Inc.
IMVT
$2.98M0.0692,346-22.72%-$876,990.251.94
Insmed Incorporated
INSM
$1.67M0.0461,718+109.21%+$874,074.161.09
Ultragenyx Pharmaceutical Inc.
RARE
$933,800.000.0220,000New+$933,800.000.61
Intra-Cellular Therapies, Inc.
ITCI
$920,360.000.0113,300New+$920,360.000.6